Parashar UD, Gibson CJ, Bresse JS, Glass RI, 2006. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12: 304ā306.
World Health Organization (WHO), 2016. Estimated Rotavirus Deaths for Children Under 5 Years of Age: 2013, 215 000. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/. Accessed July 13, 2016.
Dennehy PH, 2012. Rotavirus infection: an update on management and prevention. Adv Pediatr 59: 47ā74.
Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gomara M, Johne R, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Parreno V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M, 2011. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 156: 1397ā1413.
Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Banyai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M, 2009. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 4: 1303ā1316.
Patton JT, 2012. Rotavirus diversity and evolution in the post-vaccine world. Discov Med 13: 85ā97.
World Health Organization (WHO), 2011. Global Rotavirus Information and Surveillance Bulletin. Reporting Period: January to December. Available at: http://www.who.int/immunization/diseases/rotavirus/RV_bulletin_Jan_Dec_2011_FINAL.pdf. Accessed September 29, 2016.
Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U, 2009. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis 200: S1āS8.
Patel MM, Parashar UD, 2009. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 200: S291āS299.
Meng CY, Smith BL, Bodhidatta L, Richard SA, Vansith K, Thy B, Srijan A, Serichantalergs O, Mason CJ, 2011. Etiology of diarrhea in young children and patterns of antibiotic resistance in Cambodia. Pediatr Infect Dis J 30: 331ā335.
Logan C, O'Leary JJ, O'Sullivan N, 2006. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. J Clin Microbiol 44: 3189ā3195.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY, 1990. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 28: 276ā282.
Fischer TK, Steinsland H, Molbak K, Ca R, Gentsch JR, Valentiner-Branth P, Aaby P, Sommerfelt H, 2000. Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa. J Clin Microbiol 38: 264ā267.
Castello AA, Arguelles MH, Rota RP, Olthoff A, Jiang B, Glass RI, Gentsch JR, Glikmann G, 2006. Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J Clin Microbiol 44: 2046ā2050.
Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK, 1992. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365ā1373.
Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, Gentsch JR, Gray JJ, Kirkwood C, Page N, Iturriza-Gomara M, 2008. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 42: 368ā373.
Iturriza-Gomara M, Kang G, Gray J, 2004. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 31: 259ā265.
Thompson JD, Higgins DG, Gibson TJ, 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673ā4680.
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S, 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30: 2725ā2729.
Nyambat B, Meng CY, Vansith K, Vuthy U, Rin E, Kirkwood C, Bogdanovic-Sakran N, Kilgore PE, 2009. Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007. Vaccine 27: F81āF84.
Centers for Disease Control and Prevention (CDC), 2014. Rotavirus: Clinical Information. Available at: http://www.cdc.gov/rotavirus/clinical.html. Accessed July 13, 2016.
Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T, 2006. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 43: 312ā314.
Cubitt WD, Steele AD, Iturriza M, 2000. Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J Med Virol 61: 150ā154.
Bahl R, Ray P, Subodh S, Shambharkar P, Saxena M, Parashar U, Gentsch J, Glass R, Bhan MK, Delhi Rotavirus Study Group Members, 2005. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 192: S114āS119.
Sudarmo SM, Shigemura K, Athiyyah AF, Osawa K, Wardana OP, Darma A, Ranuh R, Raharjo D, Arakawa S, Fujisawa M, Shirakawa T, 2015. Genotyping and clinical factors in pediatric diarrhea caused by rotaviruses: one-year surveillance in Surabaya, Indonesia. Gut Pathog 7: 3.
Aupiais C, de Rougemont A, Menager C, Vallet C, Brasme JF, Kaplon J, Pothier P, Gendrel D, 2009. Severity of acute gastroenteritis in infants infected by G1 or G9 rotaviruses. J Clin Virol 46: 282ā285.
Rivera R, Forney K, Castro MR, Rebolledo PA, Mamani N, Patzi M, Halkyer P, Leon JS, Iniguez V, 2013. Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007ā2008. Int J Infect Dis 17: e762āe767.
de Rougemont A, Kaplon J, Pillet S, Mory O, Gagneur A, Minoui-Tran A, Meritet JF, Mollat C, Lorrot M, Foulongne V, Gillet Y, Nguyen-Bourgain C, Alain S, Agius G, Lazrek M, Colimon R, Fontana C, Gendrel D, Pothier P; French Rotavirus Network, 2011. Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in France. Pediatr Infect Dis J 30: 118ā124.
World Health Organization (WHO), 2014. Global Advisory Committee on Vaccine Safety, 11ā12 June 2014. Available at: http://www.who.int/vaccine_safety/committee/reports/jul_2014/en/. Accessed December 13, 2016.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy Safety Trial Study Team, 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23ā33.
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group, 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11ā22.
Abdel-Haq N, Amjad M, McGrath E, Chearskul P, Amer A, Salimnia H, Asmar BI, 2011. Emergence of human rotavirus genotype G9 in metropolitan Detroit between 2007 and 2009. J Med Microbiol 60: 761ā767.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 23 | 23 | 3 |
Full Text Views | 373 | 80 | 1 |
PDF Downloads | 66 | 13 | 0 |
Rotavirus causes significant morbidity and mortality among children worldwide. Stool samples from a previous hospital-based surveillance study to detect diarrhea etiology at the National Pediatric Hospital in Phnom Penh, Cambodia, by Meng and others in 2011 were tested for rotavirus by real-time reverse transcription polymerase chain reaction (PCR) targeting vp6 gene and characterized for G- and P-genotypes of positive samples based on vp7 and vp4 genes, respectively. Rotavirus was detected in 159/531 (30%) of children with diarrhea and none was detected in 287 nondiarrhea controls. All but three of the rotavirus-positive cases were children under the age of 2. The most common genotypes characterized by PCR and sequencing were G1P[8] (69%), G9P[8] (11%), and G2P[4] (11%). Genotype G9 was detected at a relatively high percentage that is consistent with the global trend and found to be associated with hospitalization. Data on disease burden and genotypic distribution are required information for the planning of rotavirus vaccine implementation in Cambodia.
Financial support: This project was supported by Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance (AFHSC-GEIS).
Authors' addresses: Sasikorn Silapong, Pimmada Sakpaisal, Ladaporn Bodhidatta, Paphavee Lertsethtakarn, Orntipa Sethabutr, and Brett E. Swierczewski, Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences (AFRIMS) Bangkok, Thailand, E-mails: sasikorns@afrims.org, pimmadaJ@afrims.org, ladapornb@afrims.org, paphaveeL@afrims.org, aey.orntipa@gmail.com, and brett.swierczewski.mil@afrims.org. Ket Vansith and Chhour Y. Meng, National Pediatric Hospital, Phnom Penh, Cambodia, E-mails: vansith52@gmail.com and cymeng.nph@online.com. Carl J. Mason, Seattle, WA, E-mail: carlmason@icloud.com.
Parashar UD, Gibson CJ, Bresse JS, Glass RI, 2006. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12: 304ā306.
World Health Organization (WHO), 2016. Estimated Rotavirus Deaths for Children Under 5 Years of Age: 2013, 215 000. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/. Accessed July 13, 2016.
Dennehy PH, 2012. Rotavirus infection: an update on management and prevention. Adv Pediatr 59: 47ā74.
Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gomara M, Johne R, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Parreno V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M, 2011. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 156: 1397ā1413.
Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Banyai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M, 2009. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 4: 1303ā1316.
Patton JT, 2012. Rotavirus diversity and evolution in the post-vaccine world. Discov Med 13: 85ā97.
World Health Organization (WHO), 2011. Global Rotavirus Information and Surveillance Bulletin. Reporting Period: January to December. Available at: http://www.who.int/immunization/diseases/rotavirus/RV_bulletin_Jan_Dec_2011_FINAL.pdf. Accessed September 29, 2016.
Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U, 2009. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis 200: S1āS8.
Patel MM, Parashar UD, 2009. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 200: S291āS299.
Meng CY, Smith BL, Bodhidatta L, Richard SA, Vansith K, Thy B, Srijan A, Serichantalergs O, Mason CJ, 2011. Etiology of diarrhea in young children and patterns of antibiotic resistance in Cambodia. Pediatr Infect Dis J 30: 331ā335.
Logan C, O'Leary JJ, O'Sullivan N, 2006. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. J Clin Microbiol 44: 3189ā3195.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY, 1990. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 28: 276ā282.
Fischer TK, Steinsland H, Molbak K, Ca R, Gentsch JR, Valentiner-Branth P, Aaby P, Sommerfelt H, 2000. Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa. J Clin Microbiol 38: 264ā267.
Castello AA, Arguelles MH, Rota RP, Olthoff A, Jiang B, Glass RI, Gentsch JR, Glikmann G, 2006. Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J Clin Microbiol 44: 2046ā2050.
Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK, 1992. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365ā1373.
Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, Gentsch JR, Gray JJ, Kirkwood C, Page N, Iturriza-Gomara M, 2008. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 42: 368ā373.
Iturriza-Gomara M, Kang G, Gray J, 2004. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 31: 259ā265.
Thompson JD, Higgins DG, Gibson TJ, 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673ā4680.
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S, 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30: 2725ā2729.
Nyambat B, Meng CY, Vansith K, Vuthy U, Rin E, Kirkwood C, Bogdanovic-Sakran N, Kilgore PE, 2009. Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007. Vaccine 27: F81āF84.
Centers for Disease Control and Prevention (CDC), 2014. Rotavirus: Clinical Information. Available at: http://www.cdc.gov/rotavirus/clinical.html. Accessed July 13, 2016.
Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T, 2006. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 43: 312ā314.
Cubitt WD, Steele AD, Iturriza M, 2000. Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J Med Virol 61: 150ā154.
Bahl R, Ray P, Subodh S, Shambharkar P, Saxena M, Parashar U, Gentsch J, Glass R, Bhan MK, Delhi Rotavirus Study Group Members, 2005. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 192: S114āS119.
Sudarmo SM, Shigemura K, Athiyyah AF, Osawa K, Wardana OP, Darma A, Ranuh R, Raharjo D, Arakawa S, Fujisawa M, Shirakawa T, 2015. Genotyping and clinical factors in pediatric diarrhea caused by rotaviruses: one-year surveillance in Surabaya, Indonesia. Gut Pathog 7: 3.
Aupiais C, de Rougemont A, Menager C, Vallet C, Brasme JF, Kaplon J, Pothier P, Gendrel D, 2009. Severity of acute gastroenteritis in infants infected by G1 or G9 rotaviruses. J Clin Virol 46: 282ā285.
Rivera R, Forney K, Castro MR, Rebolledo PA, Mamani N, Patzi M, Halkyer P, Leon JS, Iniguez V, 2013. Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007ā2008. Int J Infect Dis 17: e762āe767.
de Rougemont A, Kaplon J, Pillet S, Mory O, Gagneur A, Minoui-Tran A, Meritet JF, Mollat C, Lorrot M, Foulongne V, Gillet Y, Nguyen-Bourgain C, Alain S, Agius G, Lazrek M, Colimon R, Fontana C, Gendrel D, Pothier P; French Rotavirus Network, 2011. Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in France. Pediatr Infect Dis J 30: 118ā124.
World Health Organization (WHO), 2014. Global Advisory Committee on Vaccine Safety, 11ā12 June 2014. Available at: http://www.who.int/vaccine_safety/committee/reports/jul_2014/en/. Accessed December 13, 2016.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy Safety Trial Study Team, 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23ā33.
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group, 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11ā22.
Abdel-Haq N, Amjad M, McGrath E, Chearskul P, Amer A, Salimnia H, Asmar BI, 2011. Emergence of human rotavirus genotype G9 in metropolitan Detroit between 2007 and 2009. J Med Microbiol 60: 761ā767.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 23 | 23 | 3 |
Full Text Views | 373 | 80 | 1 |
PDF Downloads | 66 | 13 | 0 |